Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Dronedarone

Brand: 
NICE TA: 197
Indication: Treatment of non-permanent atrial fibrillation (NICE TA197)
Disease category: Cardiovascular system
Commissioning responsibility: CCG
PbR excluded: No

Background

Recommendation

LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

NICE TA197 - Dronedarone for the treatment of non-permanent atrial fibrillation

MHRA Drug Safety Update - Dronedarone monitoring: cardiovascular, hepatic and pulmonary adverse events

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber

Amber

Amber0

Amber0

Amber